178 related articles for article (PubMed ID: 24682943)
1. Nucleolin promotes TGF-β signaling initiation via TGF-β receptor I in glioblastoma.
Lv S; Zhang J; Han M; Wang W; Zhang Y; Zhuang D; Shi R; Bian R; Yao C
J Mol Neurosci; 2015 Jan; 55(1):1-6. PubMed ID: 24682943
[TBL] [Abstract][Full Text] [Related]
2. CrkL efficiently mediates cell proliferation, migration, and invasion induced by TGF-β pathway in glioblastoma.
Lv S; Qin J; Yi R; Coreman M; Shi R; Kang H; Yao C
J Mol Neurosci; 2013 Nov; 51(3):1046-51. PubMed ID: 23959425
[TBL] [Abstract][Full Text] [Related]
3. USP15 stabilizes TGF-β receptor I and promotes oncogenesis through the activation of TGF-β signaling in glioblastoma.
Eichhorn PJ; Rodón L; Gonzàlez-Juncà A; Dirac A; Gili M; Martínez-Sáez E; Aura C; Barba I; Peg V; Prat A; Cuartas I; Jimenez J; García-Dorado D; Sahuquillo J; Bernards R; Baselga J; Seoane J
Nat Med; 2012 Feb; 18(3):429-35. PubMed ID: 22344298
[TBL] [Abstract][Full Text] [Related]
4. Src phosphorylates Tyr284 in TGF-beta type II receptor and regulates TGF-beta stimulation of p38 MAPK during breast cancer cell proliferation and invasion.
Galliher AJ; Schiemann WP
Cancer Res; 2007 Apr; 67(8):3752-8. PubMed ID: 17440088
[TBL] [Abstract][Full Text] [Related]
5. Transforming Growth Factor β1-induced Apoptosis in Podocytes via the Extracellular Signal-regulated Kinase-Mammalian Target of Rapamycin Complex 1-NADPH Oxidase 4 Axis.
Das R; Xu S; Nguyen TT; Quan X; Choi SK; Kim SJ; Lee EY; Cha SK; Park KS
J Biol Chem; 2015 Dec; 290(52):30830-42. PubMed ID: 26565025
[TBL] [Abstract][Full Text] [Related]
6. Differential regulation of TGF-β-induced, ALK-5-mediated VEGF release by SMAD2/3 versus SMAD1/5/8 signaling in glioblastoma.
Seystahl K; Tritschler I; Szabo E; Tabatabai G; Weller M
Neuro Oncol; 2015 Feb; 17(2):254-65. PubMed ID: 25165192
[TBL] [Abstract][Full Text] [Related]
7. TbetaRI/Alk5-independent TbetaRII signaling to ERK1/2 in human skin cells according to distinct levels of TbetaRII expression.
Bandyopadhyay B; Han A; Dai J; Fan J; Li Y; Chen M; Woodley DT; Li W
J Cell Sci; 2011 Jan; 124(Pt 1):19-24. PubMed ID: 21172820
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-beta receptor type I-dependent fibrogenic gene program is mediated via activation of Smad1 and ERK1/2 pathways.
Pannu J; Nakerakanti S; Smith E; ten Dijke P; Trojanowska M
J Biol Chem; 2007 Apr; 282(14):10405-13. PubMed ID: 17317656
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of a TGFbeta receptor type-I inhibitor, Ki26894, on invasiveness of scirrhous gastric cancer cells.
Shinto O; Yashiro M; Kawajiri H; Shimizu K; Shimizu T; Miwa A; Hirakawa K
Br J Cancer; 2010 Mar; 102(5):844-51. PubMed ID: 20145621
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor (TGF-beta)-specific signaling by chimeric TGF-beta type II receptor with intracellular domain of activin type IIB receptor.
Persson U; Souchelnytskyi S; Franzén P; Miyazono K; ten Dijke P; Heldin CH
J Biol Chem; 1997 Aug; 272(34):21187-94. PubMed ID: 9261125
[TBL] [Abstract][Full Text] [Related]
11. Crk-like adapter protein is required for TGF-β-induced AKT and ERK-signaling pathway in epithelial ovarian carcinomas.
Cheng S; Guo J; Yang Q; Han L
Tumour Biol; 2015 Feb; 36(2):915-9. PubMed ID: 25307974
[TBL] [Abstract][Full Text] [Related]
12. TGF-β Targets the Hippo Pathway Scaffold RASSF1A to Facilitate YAP/SMAD2 Nuclear Translocation.
Pefani DE; Pankova D; Abraham AG; Grawenda AM; Vlahov N; Scrace S; O' Neill E
Mol Cell; 2016 Jul; 63(1):156-66. PubMed ID: 27292796
[TBL] [Abstract][Full Text] [Related]
13. C18 ORF1, a novel negative regulator of transforming growth factor-β signaling.
Nakano N; Maeyama K; Sakata N; Itoh F; Akatsu R; Nakata M; Katsu Y; Ikeno S; Togawa Y; Vo Nguyen TT; Watanabe Y; Kato M; Itoh S
J Biol Chem; 2014 May; 289(18):12680-92. PubMed ID: 24627487
[TBL] [Abstract][Full Text] [Related]
14. Negative control of the HGF/c-MET pathway by TGF-β: a new look at the regulation of stemness in glioblastoma.
Papa E; Weller M; Weiss T; Ventura E; Burghardt I; Szabó E
Cell Death Dis; 2017 Dec; 8(12):3210. PubMed ID: 29238047
[TBL] [Abstract][Full Text] [Related]
15. MAP kinase-interacting kinase 1 regulates SMAD2-dependent TGF-β signaling pathway in human glioblastoma.
Grzmil M; Morin P; Lino MM; Merlo A; Frank S; Wang Y; Moncayo G; Hemmings BA
Cancer Res; 2011 Mar; 71(6):2392-402. PubMed ID: 21406405
[TBL] [Abstract][Full Text] [Related]
16. High expression of IGFBP7 in fibroblasts induced by colorectal cancer cells is co-regulated by TGF-β and Wnt signaling in a Smad2/3-Dvl2/3-dependent manner.
Rao C; Lin SL; Ruan WJ; Wen H; Wu DJ; Deng H
PLoS One; 2014; 9(1):e85340. PubMed ID: 24427302
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of transforming growth factor-beta signaling by low molecular weight compounds interfering with ATP- or substrate-binding sites of the TGF beta type I receptor kinase.
Yakymovych I; Engström U; Grimsby S; Heldin CH; Souchelnytskyi S
Biochemistry; 2002 Sep; 41(36):11000-7. PubMed ID: 12206672
[TBL] [Abstract][Full Text] [Related]
18. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
[TBL] [Abstract][Full Text] [Related]
19. Smad and p38 MAP kinase-mediated signaling of proteoglycan synthesis in vascular smooth muscle.
Dadlani H; Ballinger ML; Osman N; Getachew R; Little PJ
J Biol Chem; 2008 Mar; 283(12):7844-52. PubMed ID: 18223258
[TBL] [Abstract][Full Text] [Related]
20. TGF-β-induced expression of IGFBP-3 regulates IGF1R signaling in human osteosarcoma cells.
Schedlich LJ; Yenson VM; Baxter RC
Mol Cell Endocrinol; 2013 Sep; 377(1-2):56-64. PubMed ID: 23831640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]